Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alfasigma S.p.a.

Clinical trials sponsored by Alfasigma S.p.a., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill could ease juvenile arthritis in kids Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Not yet finished but already full! 3 Completed 3 Terminated 1

New arthritis drug trial for kids: could filgotinib help?

Disease control Stopped early

This study is testing the drug filgotinib in children aged 8 to 17 with juvenile idiopathic arthritis (JIA), a condition causing joint pain and swelling. The goal is to see how the drug moves through the body and if it is safe. Ten children with moderate to severe JIA that is not…

Phase 1 • Sponsor: Alfasigma S.p.A. • Aim: Disease control

Last updated Jul 17, 2026 00:00 UTC